BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 2300249)

  • 1. Botulinum toxin injections for cervical dystonia.
    Jankovic J; Schwartz K
    Neurology; 1990 Feb; 40(2):277-80. PubMed ID: 2300249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin in cervical dystonia.
    Tsui JK; Calne DB
    Adv Neurol; 1988; 49():473-8. PubMed ID: 3344637
    [No Abstract]   [Full Text] [Related]  

  • 3. Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia.
    Lu CS; Chen RS; Tsai CH
    J Formos Med Assoc; 1995 Apr; 94(4):189-92. PubMed ID: 7606182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin A--injection for cervical dystonia.
    Bhaumik S; Behari M
    J Assoc Physicians India; 1999 Mar; 47(3):267-70. PubMed ID: 10999117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm.
    Jankovic J; Schwartz K; Donovan DT
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):633-9. PubMed ID: 2213039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of botulinum toxin in the treatment of cervical dystonia.
    Poewe W; Wissel J
    Baillieres Clin Neurol; 1993 Apr; 2(1):179-85. PubMed ID: 8143072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.
    Lew MF; Adornato BT; Duane DD; Dykstra DD; Factor SA; Massey JM; Brin MF; Jankovic J; Rodnitzky RL; Singer C; Swenson MR; Tarsy D; Murray JJ; Koller M; Wallace JD
    Neurology; 1997 Sep; 49(3):701-7. PubMed ID: 9305326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical correlates of response to botulinum toxin injections.
    Jankovic J; Schwartz KS
    Arch Neurol; 1991 Dec; 48(12):1253-6. PubMed ID: 1845028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BotB (botulinum toxin type B): evaluation of safety and tolerability in botulinum toxin type A-resistant cervical dystonia patients (preliminary study).
    Truong DD; Cullis PA; O'Brien CF; Koller M; Villegas TP; Wallace JD
    Mov Disord; 1997 Sep; 12(5):772-5. PubMed ID: 9380065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative electromyographical changes in cervical dystonia after treatment with botulinum toxin.
    Fuglsang-Frederiksen A; Ostergaard L; Sjö O; Werdelin L; Winkel H
    Electromyogr Clin Neurophysiol; 1998 Mar; 38(2):75-9. PubMed ID: 9553744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin in the treatment of dystonic tics.
    Jankovic J
    Mov Disord; 1994 May; 9(3):347-9. PubMed ID: 8041378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative electromyographic analysis of changes in muscle activity following botulinum toxin therapy for cervical dystonia.
    Buchman AS; Comella CL; Stebbins GT; Tanner CM; Goetz CG
    Clin Neuropharmacol; 1993 Jun; 16(3):205-10. PubMed ID: 8504437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type B: an open-label, dose-escalation, safety and preliminary efficacy study in cervical dystonia patients.
    Cullis PA; O'Brien CF; Truong DD; Koller M; Villegas TP; Wallace JD
    Adv Neurol; 1998; 78():227-30. PubMed ID: 9750919
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term botulinum toxin treatment of focal hand dystonia.
    Karp BI; Cole RA; Cohen LG; Grill S; Lou JS; Hallett M
    Neurology; 1994 Jan; 44(1):70-6. PubMed ID: 8290095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of cervical dystonia hand spasms and laryngeal dystonia with botulinum toxin.
    Lees AJ; Turjanski N; Rivest J; Whurr R; Lorch M; Brookes G
    J Neurol; 1992 Jan; 239(1):1-4. PubMed ID: 1541963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosage changes in patients with long-term botulinum toxin use for laryngeal dystonia.
    Birkent H; Maronian N; Waugh P; Merati AL; Perkel D; Hillel AD
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):43-7. PubMed ID: 19130960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromyographic guidance of botulinum toxin treatment in cervical dystonia.
    Dubinsky RM; Gray CS; Vetere-Overfield B; Koller WC
    Clin Neuropharmacol; 1991 Jun; 14(3):262-7. PubMed ID: 2070367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
    Loven JO; Brøndbo K; Ganes T
    Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patients].
    Novis SA; De Mattos JP; De Rosso AL
    Arq Neuropsiquiatr; 1995 Sep; 53(3-A):403-10. PubMed ID: 8540813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin in cervical dystonia: low dosage with electromyographic guidance.
    Brans JW; de Boer IP; Aramideh M; Ongerboer de Visser BW; Speelman JD
    J Neurol; 1995 Aug; 242(8):529-34. PubMed ID: 8530982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.